Overview

Intravenous Tranexamic Acid Versus IV Carbetocin in Abdominal Myomectomy

Status:
Not yet recruiting
Trial end date:
2020-10-20
Target enrollment:
Participant gender:
Summary
the aim of the present study is to compare safety and efficacy of intravenous tranexamic acid versus IV carbetocin in reducing blood loss during abdominal myomectomy: a randomized controlled trial
Phase:
Phase 4
Details
Lead Sponsor:
Cairo University
Treatments:
Carbetocin
Tranexamic Acid